Illness perceptions among cardiac patients: Relation to depressive symptomatology and sex

Grace, Sherry L.; Krepostman, Suzan; Brooks, Deborah; Arthur, Heather M.; Scholey, Pat; Suskin, Neville; Jaglal, Susan; Abramson, Beth L.; Stewart, Donna E.

doi:10.1016/j.jpsychores.2005.05.005

Cited by 84 publications

(91 citation statements)

References 53 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Furthermore, female patients are usually more depressed following ACS events compared to male patients. This depression negatively affects the QoL for females compared to males (38,39).…”

Section: Discussionmentioning

confidence: 99%

Quality of Life among Patients with Acute Coronary Syndrome

Aljabery¹,

Saifan²,

AbuRuz³

et al. 2017

IOSR JNHS

View full text Add to dashboard Cite

“…Furthermore, female patients are usually more depressed following ACS events compared to male patients. This depression negatively affects the QoL for females compared to males (38,39).…”

Section: Discussionmentioning

confidence: 99%

Quality of Life among Patients with Acute Coronary Syndrome

Aljabery¹,

Saifan²,

AbuRuz³

et al. 2017

IOSR JNHS

View full text Add to dashboard Cite

“…A subscale score of 0 to 8 represents subthreshold symptoms, a score of 9 to 10 represents moderate anxiety or depressive symptoms, and a score of 11 or greater represents severe symptoms. The HADS has been widely used as an anxiety and depressive symptom screening measure in hospital settings and has previously been used in cardiac research (Bjelland et al, 2002;Carless et al, 2006; S. L. Grace et al, 2005;Hevey, McGee, and Horgan, 2007;Murphy et al, 2007;Stafford, Berk, and Jackson, 2007). In the current study, the internal reliability of the depression and anxiety subscale were α=.87 and α=.83 respectively.…”

Section: Methodsmentioning

confidence: 99%

The association among depressive symptoms, smoking status and antidepressant use in cardiac outpatients

et al. 2009

Self Cite

View full text Add to dashboard Cite

Both depression and smoking are highly prevalent and related to poorer outcomes in cardiac patients. In this study, the authors examined the association between depressive symptoms and smoking status, described the frequency and type of antidepressant use, and prospectively tested the effects of antidepressant use in smokers on smoking status and psychosocial outcomes. Participants comprised 1498 coronary artery disease (CAD) outpatients who completed a baseline survey which assessed depressive symptoms, current medications, and smoking status. A second survey was mailed 9 months later that assessed depressive symptoms, anxiety, insomnia, current medications and smoking status. Results showed that current and former-smokers had significantly greater depressive symptoms than non-smokers. Ten percent of patients were taking antidepressants, most frequently SSRIs, with significantly more smokers on antidepressants than former and non-smokers. At follow-up, smokers on antidepressants were less likely to have quit, had greater anxiety, depressive symptoms and insomnia than smokers not using antidepressants. This study demonstrated that smokers and quitters with CAD had greater depressive symptoms and use of antidepressants than non-smokers, but that the antidepressants utilized may not be optimizing outcomes.

show abstract

“…In the first phase, quantitative approaches were employed using a descriptive, retrospective design. As part of a larger study (19), a baseline survey was completed in-hospital and the names of 661 consenting participants' primary care physicians were provided. In a mailed survey nine months later, the participants reported their participation (if any) in a CR program.…”

Section: Methodsmentioning

confidence: 99%